Open AccessRenin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies
Author(s) -
Chirag Bavishi,
Paul K. Whelton,
Giuseppe Mancia,
Giovanni Corrao,
Franz H. Messerli
Publication year - 2021
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/hjh.0000000000002784
Subject(s) - medicine , odds ratio , confidence interval , meta analysis , cohort study , population , cohort , relative risk , environmental health
We sought to evaluate the association of angiotensin-converting-enzyme inhibitors (ACEI) or AT1 blockers (ARB) therapy with clinical outcomes in patients with coronavirus disease 2019 (COVID-19).